CGS encourages responsible uses and effecitve governance of human genetic and assisted reproductive technologies

Featured

Biopolitical Times

Note: Originally published as “Gerechtigkeit für Henrietta Lacks” in the German publication nd; translated by the author.

Human cell lines are an instrumental part of basic biomedical research and necessary for the development of vaccines and drugs. Compared with ordinary cells in the body, cell lines in the laboratory can divide much more often, sometimes indefinitely; they are “immortalized,” either through artificial genetic changes in the laboratory or natural mutations in the development of tumors. Anyone who...

Aggregated News

The Japanese biologist Katsuhiko Hayashi said earlier this year that he believes it will be possible to create a human egg from skin cells within a decade. He and his colleagues have already turned skin cells from male mice into...

Biopolitical Times

Coded Bias is on Netflix; the trailer is
also at The Algorithmic Justice League

A few weeks ago, Marc Andreessen...

Aggregated News

All health care students worldwide should learn the history of medicine during the Nazi regime and the Holocaust, according to...

Biopolitical Times

Note: Originally published as “Gerechtigkeit für Henrietta Lacks” in the German publication nd; translated by the author...

Coded Bias is on Netflix; the trailer is
also at The Algorithmic Justice League

A few weeks ago, Marc Andreessen...

Artificial intelligence (AI), synthetic biology, and gene editing are powerful technologies that are being developed with remarkable speed and are...

News

Open letter to UK's FSA is published

A group of experts representing business, farming, certification, academia, science and civil society have lodged a formal complaint against the UK’s Food Standards Agency (FSA), raising serious concerns about its public consultation process...

In a world first, the UK medicines regulator has approved a therapy that uses the CRISPR–Cas9 gene-editing tool as a treatment. The decision marks another high point for a biotechnology that has been lauded as revolutionary in the decade since...

The first medical treatment that uses Crispr gene editing was authorized Thursday by the United Kingdom.

The one-time therapy, which will be sold under the brand name Casgevy, is for patients with sickle cell disease and a related blood disorder...

In a small initial test in people, researchers have shown that a single infusion of a novel gene-editing treatment can reduce cholesterol, the fatty substance that clogs and hardens arteries over time.

The gene-editing treatment aims to permanently lower cholesterol...

Video

Reproduction and Family Formation: The State and the Market
Use Gene Editing to Make Better Babies | Debate | Intelligence Squared U.S.
The 'Perfect' Baby?: The Dangers of Gene Editing in Assisted Reproduction